Hello all,
The recording of the Immunogenicity Discussion Group meeting on Immunogenicity assessment strategy for a chemically modified therapeutic protein in clinical development is now available to view on-demand:
Link here
Thanks,
Rob & Todd
------------------------------
Robert Nelson
Scientific Officer, Senior Director
BioAgilytix Europe GmbH
Hamburg Germany
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
------------------------------
Original Message:
Sent: 02-04-2025 16:29
From: Todd Lester
Subject: Immunogenicity Discussion Group - FEB 5th | 12PM EST
Join us for the next Immunogenicity Discussion Group on Wednesday, February 5th at 12pm EST.
We will host a presentation and discussion with Charlotte Hagman and @Maria Jadhav from Novartis -- co-authors on the recent publication: Immunogenicity assessment strategy for a chemically modified therapeutic protein in clinical development.
Submit your email address to receive a personal Teams meeting calendar invite: Submit Email Address.
Cheers!
Todd & Rob
------------------------------
Todd Lester
BioAgilytix | Senior Director
Durham, NC | [email protected]
Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------